pioglitazone has been researched along with Donohue Syndrome in 2 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Donohue Syndrome: Rare autosomal recessive syndrome of extreme insulin resistance due to mutations in the binding domain of INSULIN RECEPTOR. Clinical features include severe intrauterine and postnatal growth restriction, characteristic dysmorphic FACIES; HIRSUTISM; VIRILIZATION; multiple endocrine abnormalities, and early death.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moreira, RO | 1 |
| Zagury, RL | 1 |
| Nascimento, TS | 1 |
| Zagury, L | 1 |
| Dutta, D | 1 |
| Maisnam, I | 1 |
| Ghosh, S | 1 |
| Mukhopadhyay, S | 1 |
| Chowdhury, S | 1 |
2 other studies available for pioglitazone and Donohue Syndrome
| Article | Year |
|---|---|
Multidrug therapy in a patient with Rabson-Mendenhall syndrome.
Topics: Adamantane; Adolescent; Diabetes Mellitus, Type 2; Donohue Syndrome; Humans; Hypoglycemic Agents; Ma | 2010 |
Syndrome of extreme insulin resistance (Rabson-Mendenhall phenotype) with atrial septal defect: clinical presentation and treatment outcomes.
Topics: Adolescent; Donohue Syndrome; Female; Heart Septal Defects, Atrial; Humans; Hypoglycemic Agents; Ins | 2013 |